0001004878-20-000027.txt : 20200221
0001004878-20-000027.hdr.sgml : 20200221
20200221164750
ACCESSION NUMBER: 0001004878-20-000027
CONFORMED SUBMISSION TYPE: AW WD
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20200221
DATE AS OF CHANGE: 20200221
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: AW WD
SEC ACT:
SEC FILE NUMBER: 333-233379
FILM NUMBER: 20640754
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
AW WD
1
withdrawposerror2-20.txt
LETTER WITHDRAW POS PER ERROR
CEL-SCI CORPORATION
8229 Boone Blvd. #802
Vienna, VA 22182
(703) 506-9460
February 21, 2020
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Re: Post-Effective Amendment No. 1 to Registration Statement on Form S-1
File No. 333-233379
CEL-SCI Corporation (the "Company") requests that the request for the
withdrawal of the above-captioned Post-Effective Amendment No. 1 to registration
statement 333-233379 be withdrawn. The reason for this request is that the
previously filed request for withdrawal needed to be signed by the Company.
No securities were sold by means of the Post-Effective Amendment No. 1 to
the registration statement.
Very Truly Yours,
CEL-SCI CORPORATION
/s/ Geert R. Kersten
Geert R. Kersten
Chief Executive Officer